关键词:
  首页 > 美迪医讯 > Hemostatic Drugs and Hemocoagulase Report  

Hemostatic Drugs and Hemocoagulase Report

【 2008-07-17 发布 】 美迪医讯
美迪网领先的医疗器械电子商务平台

Hemostatic Drugs and Hemocoagulase Report

Market Research Report on Hemostatic Drugs and Hemocoagulase
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:
Format:  Hardcopy and Adobe PDF
Price:  US$1,960
Contact: Mr.Humphrey  
Tel.: 86-10-58110925            Fax:  86-10-58110918
E-mail: hhuang@medicexchange.com
 
The table of contents
1 Categories and action mechanisms of Hemostatic Drugs
2 Market status of Hemostatic Drugs
  2.1 Theoretical market capacity
  2.2 Sales trend in the past 7 years
  2.3 Market shares of different categories in 2004
  2.4 Top breeds ranked by sales value
  2.5 Leading enterprises
3 Development and application of Hemocoagulase(Batroxobin)
  3.1 Overview of Hemocoagulase
  3.2 Progress of research and development
  3.3 Characteristic of molecule structure of Hemocoagulase
  3.4 Chemical properties of Hemocoagulase
  3.5 Pharmacologic action of Hemocoagulase
  3.6 Clinic usages of Hemocoagulase
4 Sales analysis of Hemocoagulase and Reptilase
  4.1 Sales analysis of hospital market of Hemocoagulase
     4.1.1 General sales trend
     4.1.2 Competing enterprises and region distribution
  4.2 Market share comparison  of Reptilase and BaQuTing(a kind of Hemocoagulase)
  4.3 Import status of Reptilase
  4.4 Marketing status of Reptilase and BaQuTing
  4.5 Overview of Reptilase in global market
5 Brief introduction of BaQuTing
6 Brief introduction of Snake Venom Enzyme of BaiMei Pallas Pit Viper (marketed by Jingzhou ChiTai biological company)
7 Brief introduction of "ZhiXieSu"(a kind of Hemocoagulase)
8 Slaes analysis of Aprotinin
  8.1 Brief introduction of Aprotinin
  8.2 Sales status of Aprotinin in hospital market
  8.3 Competing enterprises and region distribution
9 Enterprise shares of other Hemostatic Drugs
  9.1 Competing enterprises of tranexamic acid
  9.2 Competing enterprises of prothrombin complex
  9.3 Competing enterprises of thrombin
  9.4 Competing enterprises of human fibrinogen
  9.5 Competing enterprises of Carbazochrome
  9.6 Competing enterprises of Aminomethylbenzoic Acid
  9.7 Competing enterprises of Etamsylate
本文关键字:
收藏本文到: Google书签 Digg Live Bookmark Yahoo书签 Facebook 百度搜藏 新浪ViVi 365Key网摘 天极网摘 和讯网摘 POCO网摘 QQ书签

  《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询

我要评论:《Hemostatic Drugs and Hemocoagulase Report》
匿名发表 我的名字: Email: 验证码: 点击可刷新
 
    
合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图
把美迪网放进收藏夹  把美迪医疗网介绍给我的朋友  给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303    美迪医疗网业务咨询
互联网药品信息服务许可证:(沪)-经营性-2009-0003   中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 沪ICP备14001091号-8
 
公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号
营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081
消防排烟风机 华创商务网
美迪医疗网广告业务联系:021-51601230  产品咨询业务联系:021-51601230 传真:021-56532303   美迪医疗网产品咨询 本QQ仅咨询广告和会员业务,不咨询产品和药品等业务美迪医疗网推广业务咨询